On today's episode we'll talk about the new coeliac disease trial named DAISY which is testing the effectiveness of a coeliac disease drug for those who are adhering to a gluten free diet but experiencing ongoing symptoms.
What we'll cover: * Nicole in our podcast Facebook group sharing a Nine News segment on a new coeliac disease clinical alongside a woman's coeliac disease and gluten free journey * Sharing this news segment on social media and gaining insights from the comments section * What is this new coeliac disease clinical trial? * Defining the DAISY Study * How the clinical trial works and the aims of the study * The eligibility for interest and participation for this clinical trial * My thoughts around this current coeliac disease clinical trial * Larazotide Acetate reaching Phase 3 in clinical trial but discontinued * Living a gluten free life alongside you * Being able to have another intervention other than a gluten free diet * Questions I have around this potential drug for treating coeliac disease symptoms * Interleukin 2 blood test holding hope * Professor Jason Tye talking about the Interleukin 2 blood tests, updates around oats and more coeliac disease research updates * Why remaining curious and asking why is so important in our coeliac disease and gluten free lives * Keeping you up-to-date with coeliac disease research
Podden och tillhörande omslagsbild på den här sidan tillhör
Ben Hampton. Innehållet i podden är skapat av Ben Hampton och inte av,
eller tillsammans med, Poddtoppen.
